Data / Form D filings / OptiNose, Inc.
OptiNose, Inc.: Form D filings
OptiNose, Inc., a pharmaceuticals company in Yardley, PA, filed 9 Form D notices with the SEC between 2010 and 2024. The latest, on May 20, 2024, reports $4.7 million sold of a $4.7 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1020 Stony Hill Road, Suite 300, Yardley, PA, 19067
- Phone
- (267) 364-3500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1494650
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 20, 2024 | New notice | $4,680,000 | $4,680,000 | 2 | May 10, 2024 | sec.gov | |
| Nov 30, 2021 | New notice | $4,000,000 | $4,000,000 | 2 | Nov 16, 2021 | sec.gov | |
| Aug 19, 2020 | New notice | $250,000 | $250,000 | 2 | Aug 18, 2020 | sec.gov | |
| Sep 25, 2019 | New notice | $5,445,599 | $5,445,599 | 2 | Sep 12, 2019 | sec.gov | |
| Apr 7, 2017 | New notice | $35,000,065 | $35,000,065 | 8 | Mar 24, 2017 | sec.gov | |
| Oct 13, 2015 | Amendment | $34,999,943 | $34,999,943 | 23 | Jul 22, 2014 | sec.gov | |
| Oct 13, 2015 | New notice | $30,000,000 | $15,000,000 | $15,000,000 | 21 | Sep 30, 2015 | sec.gov |
| Aug 4, 2014 | New notice | $34,999,943 | $29,999,972 | $4,999,971 | 23 | Jul 22, 2014 | sec.gov |
| Jun 21, 2010 | New notice | $48,750,011 | $21,055,999 | $27,694,012 | 23 | Jun 7, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul A. Spence | Executive Officer | |
| Catherine E. Owen | Director | |
| Wilhelmus John Groenhuysen | Director | |
| Eric John Bednarski | Director | |
| Tomas J. Heyman | Director | |
| Sandra L. Helton | Director | |
| Kyle John Dempsey | Director | |
| Ramy A. Mahmoud | Director, Executive Officer | |
| Michael F. Marino | Executive Officer | |
| R. John Fletcher | Director | |
| Anthony J. Krick | Executive Officer |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of May 20, 2024 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what OptiNose, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.